Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
14.43
Dollar change
+0.29
Percentage change
2.05
%
Index- P/E- EPS (ttm)-0.48 Insider Own0.01% Shs Outstand1.12B Perf Week7.05%
Market Cap16.18B Forward P/E5.48 EPS next Y2.64 Insider Trans-85.80% Shs Float1.12B Perf Month8.50%
Income-527.00M PEG- EPS next Q0.52 Inst Own52.47% Short Float0.93% Perf Quarter37.69%
Sales15.84B P/S1.02 EPS this Y-6.30% Inst Trans9.55% Short Ratio0.96 Perf Half Y41.19%
Book/sh6.70 P/B2.16 EPS next Y9.87% ROA-1.20% Short Interest10.46M Perf Year65.29%
Cash/sh2.88 P/C5.01 EPS next 5Y1.60% ROE-6.84% 52W Range7.09 - 14.23 Perf YTD38.22%
Dividend Est.- P/FCF6.98 EPS past 5Y26.63% ROI-2.03% 52W High1.42% Beta1.05
Dividend TTM- Quick Ratio0.69 Sales past 5Y-2.68% Gross Margin48.24% 52W Low103.67% ATR (14)0.32
Dividend Ex-DateNov 27, 2017 Current Ratio1.02 EPS Y/Y TTM77.75% Oper. Margin20.15% RSI (14)74.85 Volatility2.09% 2.39%
Employees37226 Debt/Eq2.70 Sales Y/Y TTM6.11% Profit Margin-3.33% Recom1.92 Target Price15.75
Option/ShortYes / Yes LT Debt/Eq2.46 EPS Q/Q136.88% Payout- Rel Volume1.08 Prev Close14.14
Sales Surprise10.69% EPS Surprise30.29% Sales Q/Q13.62% EarningsJan 31 BMO Avg Volume10.90M Price14.43
SMA206.50% SMA5012.83% SMA20042.31% Trades Volume12,252,173 Change2.05%
Date Action Analyst Rating Change Price Target Change
Mar-08-24Upgrade JP Morgan Underweight → Neutral $14
Feb-12-24Upgrade Piper Sandler Neutral → Overweight $12 → $19
Jan-23-24Upgrade Jefferies Hold → Buy $10 → $14
Jan-03-24Upgrade Piper Sandler Underweight → Neutral $8 → $12
Dec-18-23Initiated HSBC Securities Buy $13
Nov-27-23Upgrade UBS Neutral → Buy $11 → $13
Jul-06-23Upgrade UBS Sell → Neutral $7 → $8
May-25-23Initiated Morgan Stanley Equal-Weight $10
May-18-23Upgrade Evercore ISI In-line → Outperform
Jan-19-23Downgrade Jefferies Buy → Hold $10 → $12
Mar-24-24 07:30PM
Mar-21-24 11:10PM
Mar-18-24 03:06PM
Mar-08-24 05:00AM
Feb-26-24 02:19PM
09:58AM Loading…
09:58AM
07:00AM
Feb-23-24 08:15PM
Feb-20-24 08:30AM
04:43AM
04:00AM
Feb-16-24 09:04AM
08:57AM
Feb-13-24 12:08AM
Feb-12-24 10:18AM
05:02PM Loading…
Feb-09-24 05:02PM
Feb-05-24 09:02AM
Feb-01-24 11:42AM
Jan-31-24 04:05PM
03:51PM
02:55PM
01:30PM
01:07PM
10:30AM
10:20AM
09:09AM
08:10AM
07:52AM
07:20AM
07:00AM
06:32AM Loading…
06:32AM
06:20AM
06:00AM
Jan-28-24 12:42PM
Jan-26-24 09:15AM
Jan-25-24 09:40AM
Jan-23-24 01:43AM
Jan-12-24 09:00AM
Jan-10-24 05:21AM
Jan-02-24 04:30PM
Dec-29-23 06:43PM
06:34PM
06:14PM
Dec-28-23 04:30PM
Dec-26-23 10:51AM
Dec-22-23 10:54AM
Dec-21-23 05:45AM
Dec-15-23 05:21AM
Dec-14-23 08:30AM
Dec-07-23 02:03PM
Dec-06-23 02:00AM
Nov-30-23 08:30AM
Nov-27-23 10:14AM
09:56AM
09:37AM
08:15AM
01:50AM
Nov-24-23 08:16PM
Nov-20-23 04:30PM
Nov-17-23 08:30AM
Nov-15-23 07:03PM
Nov-13-23 08:10AM
08:00AM
Nov-12-23 12:02AM
Nov-09-23 01:21PM
Nov-08-23 04:31PM
04:01PM
03:05PM
02:15PM
01:22PM
12:05PM
09:30AM
09:01AM
08:04AM
07:40AM
07:37AM
07:27AM
07:00AM
Nov-07-23 04:30PM
Nov-02-23 11:23AM
08:00AM
Nov-01-23 07:31PM
Oct-30-23 04:35PM
Oct-25-23 09:00AM
Oct-18-23 04:56AM
Oct-17-23 01:30AM
Oct-10-23 12:26PM
10:52AM
Oct-06-23 05:11PM
04:30PM
Oct-04-23 07:45PM
04:08PM
10:47AM
10:37AM
01:07AM
Sep-28-23 04:05PM
Sep-26-23 04:33PM
Sep-20-23 07:34PM
Sep-13-23 05:21AM
Sep-06-23 04:30PM
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kalif Eliyahu SharonEVP, Chief Financial OfficerMar 06 '24Sale13.5277,5501,048,119203,691Mar 07 04:27 PM
Sabag MarkEVP, International MarketsMar 05 '24Sale13.52100,0001,352,090382,590Mar 07 04:12 PM
Daniell RichardExec. VP, European CommercialMar 05 '24Sale13.5248,629657,24069,770Mar 07 04:20 PM
Conway Vikki LSee "Remarks"Mar 05 '24Sale13.521,42719,28615,219Mar 07 04:16 PM
Daniell RichardExec. VP, European CommercialMar 04 '24Sale13.3495,7621,277,20769,770Mar 05 04:21 PM
Francis Richard DPresident and CEOMar 04 '24Sale13.3431,061414,270123,295Mar 05 04:27 PM
Hughes Eric ASee "Remarks"Mar 04 '24Sale13.348,045107,29916,855Mar 05 04:16 PM
Conway Vikki LSee "Remarks"Mar 04 '24Sale13.373,53247,2346,617Mar 05 04:39 PM
Daniell RichardExec. VP, European CommercialFeb 28 '24Sale13.1220,599270,17669,770Mar 01 06:43 AM
Drape EricExecutive VP Global OperationsFeb 28 '24Sale13.129,815128,7349,701Mar 01 06:45 AM
Conway Vikki LSee "Remarks"Feb 28 '24Sale13.121,36617,9162,928Mar 01 06:40 AM
Drape EricExecutive VP Global OperationsFeb 16 '24Sale13.05173,2612,261,9051Feb 21 07:37 AM
Francis Richard DPresident and CEOFeb 15 '24Sale13.1574,530980,17487,125Feb 20 07:42 AM
Weiss AmirChief Accounting OfficerFeb 01 '24Sale12.3731,766392,95510,676Feb 05 07:49 AM
Kalif Eliyahu SharonEVP, Chief Financial OfficerAug 07 '23Sale9.7335,125341,88999,162Aug 09 04:02 PM
Weiss AmirChief Accounting OfficerAug 04 '23Sale9.921,98119,65842,442Aug 07 04:15 PM
Hughes Eric ASee "Remarks"Aug 01 '23Sale8.3052,742437,6900Aug 03 07:09 AM